Revolution Medicines thinks it could transform the treatment of pancreatic cancer – one of the hardest forms to treat – based on phase 3 data with its pan-RAS(on) inhibitor daraxonrasib. The company ...

The modified BMW M2 LCI 2025 pushes performance to 580hp, transforming how it feels on the road. But can it handle the extra power, or does it become too much to control John Roberts defends Supreme ...

Researchers from the Department of Energy's Quantum Science Center (QSC) headquartered at Oak Ridge National Laboratory (ORNL) have achieved a significant milestone by demonstrating the first digital ...

Revolution Medicines’ pan-RAS inhibitor helped patients with a highly aggressive form of pancreatic cancer live an average of six months longer than chemotherapy, hitting a goal of the phase 3 study.

A Revolution Medicines drug helped pancreatic cancer patients live nearly six months longer compared to those treated with standard of care chemotherapy, meeting the goals of a pivotal study in this ...

College choirs are more than a place to sing—they’re spaces where students grow academically, emotionally, and socially. From building confidence to forging friendships, they enrich campus life and ...